These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1978762)

  • 1. Virologic and immunologic aspects of acquired immunodeficiency syndrome.
    Lane HC
    Surg Gynecol Obstet; 1990; 171 Suppl():11-8. PubMed ID: 1978762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update.
    Schnittman SM; Fauci AS
    Adv Intern Med; 1994; 39():305-55. PubMed ID: 8140958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
    Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.
    Carcelain G; Tubiana R; Samri A; Calvez V; Delaugerre C; Agut H; Katlama C; Autran B
    J Virol; 2001 Jan; 75(1):234-41. PubMed ID: 11119593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.
    McCormick-Davis C; Dalton SB; Hout DR; Singh DK; Berman NE; Yong C; Pinson DM; Foresman L; Stephens EB
    Virology; 2000 Jun; 272(1):112-26. PubMed ID: 10873754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic and virologic markers determining progression to AIDS.
    Schellekens PT; Koot M; Roos MT; Tersmette M; Miedema F
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S62-6. PubMed ID: 7552515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy for human immunodeficiency virus infection in 1997.
    Katzenstein DA
    West J Med; 1997 May; 166(5):319-25. PubMed ID: 9217434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus infection in children: nature of immunodeficiency, clinical spectrum and management.
    Pahwa S
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S61-71. PubMed ID: 3041360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection.
    Henrard DR; Daar E; Farzadegan H; Clark SJ; Phillips J; Shaw GM; Busch MP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):305-10. PubMed ID: 7788430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.
    Notermans DW; Pakker NG; Hamann D; Foudraine NA; Kauffmann RH; Meenhorst PL; Goudsmit J; Roos MT; Schellekens PT; Miedema F; Danner SA
    J Infect Dis; 1999 Oct; 180(4):1050-6. PubMed ID: 10479130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HIV-1 infection: pathogenesis of immune suppression].
    Stingl G
    Wien Med Wochenschr; 1988 Oct; 138(19-20):487-92. PubMed ID: 2904717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
    Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis, natural history, and classification of HIV infection.
    Libman H
    Prim Care; 1992 Mar; 19(1):1-17. PubMed ID: 1594691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of vitamin E in the treatment of immunologic abnormalities during acquired immune deficiency syndrome.
    Odeleye OE; Watson RR
    Prog Food Nutr Sci; 1991; 15(1-2):1-19. PubMed ID: 1887063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphoid germinative centers reservoir of HIV].
    Di Nola F
    Minerva Pediatr; 1992; 44(7-8):387-8. PubMed ID: 1357536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.